About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
722
By Phase
PHASE2: 3PHASE1: 2PHASE3: 1PHASE4: 3
By Status
COMPLETED: 4TERMINATED: 3UNKNOWN: 1SUSPENDED: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05684952Collaborator
The Efficacy and Safety of a Chinese Herbal Medicine for Long COVID Associated Fatigue
PHASE2Unknown
152 participants
Started: May 30, 2023 · Completed: Feb 1, 2024
NCT05588557Lead Sponsor
A Phase I Study to Evaluate the Safety and PK of ND-340 in Healthy Volunteers
PHASE1Completed
24 participants
Started: Jul 8, 2022 · Completed: Mar 19, 2024
NCT07116863Lead Sponsor
A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension
PHASE3Completed
286 participants
Started: Jun 21, 2022 · Completed: Sep 13, 2024
NCT04515953Lead Sponsor
A Phase I Dose-escalation Study of a Single Administration of Extended-Release Injectable Suspension (ND-340)
PHASE1Suspended
36 participants
Started: Oct 15, 2020 · Completed: Jun 30, 2026
NCT02017600Lead Sponsor
A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus
PHASE2Terminated
48 participants
Started: Aug 31, 2013 · Completed: Apr 4, 2015
Locations (1)
Headquarters
Seoul, Korea
Map
Loading map...